Filing Details
- Accession Number:
- 0001576885-25-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-23 17:16:46
- Reporting Period:
- 2025-01-21
- Accepted Time:
- 2025-01-23 17:16:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576885 | Acumen Pharmaceuticals Inc. | ABOS | Biological Products, (No Disgnostic Substances) (2836) | 364108129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1752461 | M Derek Meisner | C/O Acumen Pharmaceuticals, Inc. 1210-1220 Washington Street, Suite 210 Newton MA 02465 | Chief Legal Officer & Corp Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-21 | 3,418 | $1.59 | 161,127 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2024.
Billionaire Hedge Funds
